ASR Vermogensbeheer N.V. Takes $7.59 Million Position in Cardinal Health, Inc. (NYSE:CAH)

ASR Vermogensbeheer N.V. purchased a new stake in Cardinal Health, Inc. (NYSE:CAHFree Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 55,102 shares of the company’s stock, valued at approximately $7,592,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Marshall Wace LLP increased its stake in shares of Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after buying an additional 1,913,892 shares during the period. Castlekeep Investment Advisors LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at about $141,963,000. GAMMA Investing LLC grew its stake in Cardinal Health by 17,589.1% during the first quarter. GAMMA Investing LLC now owns 964,941 shares of the company’s stock worth $132,940,000 after purchasing an additional 959,486 shares during the period. Junto Capital Management LP acquired a new stake in Cardinal Health during the fourth quarter worth approximately $92,811,000. Finally, Woodline Partners LP acquired a new stake in Cardinal Health during the fourth quarter worth approximately $87,144,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.9%

CAH stock opened at $156.78 on Thursday. Cardinal Health, Inc. has a twelve month low of $96.05 and a twelve month high of $168.44. The stock’s 50 day moving average is $160.00 and its 200-day moving average is $143.36. The firm has a market capitalization of $37.42 billion, a PE ratio of 24.46, a P/E/G ratio of 1.57 and a beta of 0.67.

Analysts Set New Price Targets

CAH has been the subject of several recent analyst reports. Bank of America raised their target price on Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a research note on Tuesday, June 10th. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. UBS Group raised their target price on Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Tuesday, April 29th. Citigroup reaffirmed a “neutral” rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Finally, Wells Fargo & Company raised Cardinal Health from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $136.00 to $179.00 in a research note on Tuesday, June 3rd. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $158.07.

Get Our Latest Analysis on CAH

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.